BeyondSpring Reports Third-Quarter 2026 Financial Results and Provides Corporate UpdateGlobeNewswire Nov 13, 2026, 10:15:39 PM
BeyondSpring Announces FDA Fast Track Designation for Plinabulin in Post-ICI Non-Squamous NSCLC and Strategic Transaction to Advance Global Phase 3 DUBLIN-4 Trial Toward Planned Interim AnalysisGlobeNewswire Sep 29, 2026, 11:01:00 AM